Peptide–drug conjugates with different linkers for cancer therapy

M Alas, A Saghaeidehkordi, K Kaur - Journal of medicinal …, 2020 - ACS Publications
Drug conjugates are chemotherapeutic or cytotoxic agents covalently linked to targeting
ligands such as an antibody or a peptide via a linker. While antibody–drug conjugates …

Preclinical and clinical development of siRNA-based therapeutics

G Ozcan, B Ozpolat, RL Coleman, AK Sood… - Advanced drug delivery …, 2015 - Elsevier
The discovery of RNA interference, first in plants and Caenorhabditis elegans and later in
mammalian cells, led to the emergence of a transformative view in biomedical research …

Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications

B Döme, MJC Hendrix, S Paku, J Tóvári… - The American journal of …, 2007 - Elsevier
Although cancer cells are not generally controlled by normal regulatory mechanisms, tumor
growth is highly dependent on the supply of oxygen, nutrients, and host-derived regulators. It …

Emerging strategies for EphA2 receptor targeting for cancer therapeutics

M Tandon, SV Vemula, SK Mittal - Expert opinion on therapeutic …, 2011 - Taylor & Francis
Importance of the field: High mortality rates with cancers warrant further development of
earlier diagnostics and better treatment strategies. Membrane-bound erythropoietin …

The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting

J Wykosky, W Debinski - Molecular Cancer Research, 2008 - AACR
The Eph receptor tyrosine kinases and ephrin ligands have been studied extensively for
their roles in developmental processes. In recent years, Eph receptors and ephrins have …

Molecular mechanisms of tumor angiogenesis

S Ziyad, ML Iruela-Arispe - Genes & cancer, 2011 - journals.sagepub.com
Tumors have been recently recognized as aberrant organs composed of a complex mixture
of highly interactive cells that in addition to the cancer cell include stroma (fibroblasts …

The pathology and genetics of metastatic pancreatic cancer

S Yachida… - Archives of pathology & …, 2009 - meridian.allenpress.com
Context.—Metastatic disease is the most critical determinant of resectability of pancreatic
cancer and accounts for the poor outcome of patients with this disease. Thus, a better …

Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors

J You, R Zhang, C Xiong, M Zhong, M Melancon… - Cancer research, 2012 - AACR
Photothermal ablation (PTA) is an emerging technique that uses near-infrared (NIR) laser
light–generated heat to destroy tumor cells. However, complete tumor eradication by PTA …

Regulation of angiogenesis by Eph–ephrin interactions

S Kuijper, CJ Turner, RH Adams - Trends in cardiovascular medicine, 2007 - Elsevier
The large families of Eph receptor tyrosine kinases and their ephrin ligands transduce
signals in a cell-cell contact-dependent fashion and thereby coordinate the growth …

Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth

NK Noren, M Lu, AL Freeman… - Proceedings of the …, 2004 - National Acad Sciences
Receptor tyrosine kinases of the Eph family are up-regulated in different types of cancer.
EphB4 and its ligand ephrin-B2 have been linked to breast cancer, but little is known about …